Homology Medicines, Inc. QTTB 深 沪
等待开盘 05-21 09:30:00 美东时间
5.72
-0.350
-5.77%
华盛通- 最 高6.07
- 今 开6.02
- 成交量 15.23万股
- 最 低 5.64
- 昨 收 6.07
- 总市值 9699.07万
- 52周最高 8.045
- 市盈率 静 2.36
- 换手率 0.90%
- 52周最低 1.345
- 委 比 87.58%
- 总股本 1695.64万
- 历史最高 572.40
- 量 比 0.85
- 振 幅 7.08%
- 历史最低 1.345
- 每 手 1
- 风险率 1.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cantor Fitzgerald Initiates Coverage On Q32 Bio with Overweight Rating
Cantor Fitzgerald initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Overweight rating.
05-18 23:19
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
HC Wainwright & Co. Reiterates Buy on Q32 Bio, Maintains $13 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Q32 Bio (NASDAQ:QTTB) with a Buy and maintains $13 price target.
05-06 00:14
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Q32 Bio Q1 EPS $(0.54) Beats $(0.68) Estimate
Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.68) by 20.59 percent. This is a 40 percent increase over losses of $(0.90) per share from the same
05-05 19:09
Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Organon & Co (OGN) jumped 14.8% in pre-market trading as Sun Pharma agreed to acquire the company for $11.75 billion, $2 higher than current price.
04-27 16:45
美股夜盘 | Homology Medicines, Inc.跌20.58%，最新股价4.94美元
Homology Medicines, Inc.跌20.58%，报4.94美元
04-27 10:01
美股夜盘 | Aditxt, Inc.涨34.85%，Intellia Therapeutics, Inc.涨24.21%
Cheetah Net Supply Chain Service, Inc. Class A涨-24.71%；香颂国际涨-17.80%；Homology Medicines, Inc.涨-13.02%
04-27 08:05
Q32 Bio Files Prospectus To Launch New $75M At-The-Market Offering Program
As previously disclosed, on March 27, 2026, Q32 Bio Inc. (the "Company") entered into a Controlled Equity OfferingSM Sales Agreement (the "Sales Agreement") with Cantor Fitzgerald & Co. (the "Sales Agent"),
04-25 04:12
Q32 Bio Files Prospectus To Offer And Sell Common Stock Up To $14.2M Through Cantor
-SEC Filing
03-28 05:25
